Health and Medicine
Nov. 23, 2020—Women diagnosed with early-onset colorectal cancer have a greater risk of dying from the disease depending upon their county of residence, according to a study published in Clinical and Translational Gastroenterology.
Ridner returns to cancer patient research and care during Research Ramp-up to advance intervention studies
Nov. 20, 2020—When in-person research activities at Vanderbilt were put on hold in mid-March due to the COVID-19 pandemic, nursing professor Sheila Ridner’s steadfast commitment to patients ensured that their care did not suffer.
Nov. 19, 2020—Modernized endoscopic system blends robotics and magnetic coupling to improve medical procedures, starting with colonoscopies.
Why does COVID-19 seem to spare children? Vanderbilt University Medical Center study offers an answer
Nov. 18, 2020—Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children.
Nov. 18, 2020—A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.
Nov. 17, 2020—Further research by biochemistry professors Charles Sanders and Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research.
Nov. 17, 2020—Vanderbilt biochemists figure out how the little-understood Envelope protein helps SARS-CoV-2 function and how to disrupt the endogenously creative virus.
Nov. 16, 2020—Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19.
Nov. 12, 2020—Vanderbilt contributes molecular imaging data of kidney to the Human BioMolecular Atlas Program, a consortium of 18 diverse collaborative research teams across the United States and Europe.
Nov. 12, 2020—Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer.
Nov. 12, 2020—A new study from Vanderbilt epidemiologists suggests that it’s time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women.
Nov. 11, 2020—Vanderbilt University Medical Center health policy experts share what’s next for drug policy, insurance coverage, health care access and pandemic response in a free virtual discussion on Monday, Nov. 16.